Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl）-β-D-glucoside
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl）-β-D-glucoside
CAS No. 1333206-55-5
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl）-β-D-glucoside( ——— )
Catalog No. M39746 CAS No. 1333206-55-5
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl）-β-D-glucoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl）-β-D-glucoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionPelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl）-β-D-glucoside
-
DescriptionPelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl）-β-D-glucoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1333206-55-5
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SynuClean-D
SynuClean-D is an α-synuclein aggregation inhibitor preventing fibril propagation, disrupting mature amyloid fibrils, and abolishing the degeneration of dopaminergic neurons in an animal model of Parkinson’s disease.
-
B I09
B I09, an IRE-1 RNase inhibitor with an IC50 of 1230 nM, inhibits splicing of XBP1 mRNA in human WaC3 cells and expression of xbp-1 in LPS-stimulated B cells. B I09 can be used to simulate the defects of XBP-1 in CLL cells.
-
L-Pyroglutamic acid
A cyclized derivative of l-glutamic acid. Elevated blood levels may be associated with problems of glutamine or glutathione metabolism.
